N,N,N',N'-tetrasubstituted-1,2-ethanediamine derivative compounds

PCT No. PCT/EP94/02363 Sec. 371 Date Apr. 21, 1995 Sec. 102(e) Date Apr. 21, 1995 PCT Filed Jul. 18, 1994 PCT Pub. No. WO95/03270 PCT Pub. Date Feb. 2, 1995The invention relates to new N,N,N'N'-tetra-substituted-1,2-ethanediamine compounds of the general formula (I): (I) wherein X is a car...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GUBERT, SANTIAGO, ORTIZ, JOS+E,ACU E+EE, FOGUET, RAFAEL, SACRIST+E,GRA A+EE N, AURELIO, CASTELL+E,ACU O+EE, JOSEP M
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PCT No. PCT/EP94/02363 Sec. 371 Date Apr. 21, 1995 Sec. 102(e) Date Apr. 21, 1995 PCT Filed Jul. 18, 1994 PCT Pub. No. WO95/03270 PCT Pub. Date Feb. 2, 1995The invention relates to new N,N,N'N'-tetra-substituted-1,2-ethanediamine compounds of the general formula (I): (I) wherein X is a carbonyl (CO), hydroxymethylen (CHOH) or p-fluorophenyl-methylen (p-F-C6H4-CH) group and R is a benzyl group optionally substituted in p- with an halogen, or R is a 2-pyrimidinyl group with the proviso that simultaneously X may not be p-fluorophenyl-methylen (p-F-C6H4-CH) and R may not be an unsubstituted benzyl group, as well as their pharmaceutically acceptable additions salts. The compounds are potentially useful in the treatment of sigma receptor-related nervous system diseases.